Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Pharmacotherapy|September 19, 2001
Substance P: a new era, a new roleC L DeVane
The Annals of Pharmacotherapy|February 11, 1999
No mourning for the conventional antipsychotics: the dawn of the atypical agentsC L DeVane
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 1, 1995
Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugsC L DeVane
The Journal of Clinical Psychiatry|January 9, 1999
Differential pharmacology of newer antidepressantsC L DeVane
Cellular and Molecular Neurobiology|June 24, 1999
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitorsC L DeVane
The Journal of Clinical Psychiatry|December 1, 1994
Pharmacogenetics and drug metabolism of newer antidepressant agentsC L DeVane
Clinics in Laboratory Medicine|September 1, 1987
Monitoring cyclic antidepressantsC L DeVane
Psychopharmacology Bulletin|October 26, 2002
An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacologyC L DeVane, H L Liston
Immunopharmacology and Immunotoxicology|January 1, 1991
Immunologic effects of cocaine and related alkaloidsJ C Delafuente, C L DeVane
Drug Intelligence & Clinical Pharmacy|September 1, 1985
Buspirone: a new type of anxiolyticC S Dommisse, C L DeVane
Pageof 13